JPRN-UMIN000053539招募中Unknown
Effects of combined therapy of imeglimin and hypolipidemic agents on metabolic parameter in patients with type 2 diabetes - Effects of combined therapy of imeglimin and hypolipidemic agents on metabolic parameter in patients with type 2 diabetes
Akishima Clinic0 个研究点目标入组 100 人开始时间: 2024年2月5日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •eGFR: less than 45 mL/min/1.73m2
研究者
相似试验
招募中
不适用
Prospective study of the efficacy of imeglimin and metformin against insulin secretion and resistance in patients with type 2 diabetesType 2 diabetesD003924JPRN-jRCTs051220075Hamamoto Yoshiyuki40
进行中（未招募）
不适用
Imeglimin add-on therapy:A randomized, double-blind, clinical trialType 2 diabete mellitusJPRN-jRCTs061210082Shimoda Masashi200
进行中（未招募）
1 期
H1-antihistaminE treatment in combiNation with immunotHerapy in pAtieNts with advanced non small cell lung canCEr: A single- center phase II trialSCLCEUCTR2022-001284-27-ATMed. Univ. Wien, Klinik f. Innere Med I, Onkologie9
招募中
2 期
Imeglimin hydrochloride for NAFLD with type 2 diabetes: phase II studyJPRN-jRCTs051220094Kitano Masayuki27
尚未招募
3 期
A Clinical Trial To Compare The Efficacy And Safety Of Imeglimin ( A Novel Anti-Diabetic agent) With Existing Anti-Diabetic Agents In Newly Diagnosed Type 2 Diabetes Patients.CTRI/2023/11/060291Government Medical College, Jammu